Skip to content
HowShorted

ATOSSA THERAPEUTICS, INC. short interest in 2020

In 2020, ATOSSA THERAPEUTICS, INC.'s disclosed short interest ran from 3.63% of shares outstanding on 15 Jan 2020 to 6.32% on 31 Dec 2020, a change of +2.69 percentage points. The year's high was 6.32% on 31 Dec 2020 and its low 1.27% on 15 Sep 2020, averaging 2.63% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.59 days on 14 Feb 2020. Full history: ATOSSA THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ATOSSA THERAPEUTICS, INC. in 2020

2020 in figures

Start of year
3.63% (15 Jan 2020)
End of year
6.32% (31 Dec 2020)
Change
+2.69 pp
High
6.32% (31 Dec 2020)
Low
1.27% (15 Sep 2020)
Average
2.63%
Highest days to cover
5.59 (14 Feb 2020)
SEC filings marked
8

Every report in 2020

ATOSSA THERAPEUTICS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20203.63%3.66
31 Jan 20202.60%3.72
14 Feb 20202.54%5.59
28 Feb 20202.48%3.13
13 Mar 20202.49%2.41
31 Mar 20202.65%1.6610-K filed, results (8-K)
15 Apr 20202.62%1.00
30 Apr 20202.81%1.00
15 May 20202.28%1.0010-Q filed, results (8-K)
29 May 20203.35%1.00
15 Jun 20202.58%1.00
30 Jun 20202.12%1.00
15 Jul 20201.85%1.00
31 Jul 20201.95%1.00
14 Aug 20202.46%1.0010-Q filed, results (8-K)
31 Aug 20201.96%1.00
15 Sep 20201.27%1.00
30 Sep 20201.96%1.00
15 Oct 20201.66%1.55
30 Oct 20201.92%1.28
13 Nov 20202.77%2.3310-Q filed, results (8-K)
30 Nov 20204.24%2.50
31 Dec 20206.32%1.00

See also: ATOSSA THERAPEUTICS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.